This announcement is a separate document:
昭衍新药：北京昭衍新药研究中心股份有限公司2021年年度A股权益分派实施公告
Zhaoyan Pharmaceutical: Beijing Zhaoyan New Drug Research Center Co., Ltd.'s 2021 A-share equity allocation implementation announcement
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.